Calculator Template: Difference between revisions

Latest revision as of 16:41, 5 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)

Synonyms and keywords: (add synonyms and create redirects)

Overview

[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score]

[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] Calculator

Shown below is the calculator for [Name of the Score] (check all the boxes that apply):

(insert widget here) {{#widget:Widget_Name}}

Interpretation

Score ≤ 1: low-risk (< 1% mortality); no treatment or hospital admission is required.
Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.

References

@@ Line 5: / Line 5: @@
 ==Overview==
-[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other endpoints) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other conditions).
+[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
 ==[Name of the Score]==
+[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)
-===Historical Perspective===
+[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
-[Name of the Score] was invented by (Author) et al in (year).(add reference)
-===Purpose===
-[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other endpoints) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other conditions).
 [Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.
-[Name of the Score] is a (prediction model) created to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).
+[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).
 [Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).
-===Components===
-[Name of the Score] consists of (number) parameters including clinical variables (age/sex/weight/creatinine clearance/past history/clinical presentation), laboratory values (WBC/hemoglobin/platelet), and imaging findings (diffuse pulmonary infiltrates/prolonged QT interval).
-===Interpretation===
-* Score ≤1: low-risk (<1% mortality); no treatment or hospital admission is needed.
-* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
-* Score ≥4: high-risk (>5% mortality); treatment/hospitalization is needed.
-===Performance===
-[Name of the Score] demonstrates modest discrimination (c statistic 0.64 [95% CI, 0.66 to 0.88]).
-===Guideline Recommendations===
-[Name of the Score] has been included in the (ACC/AHA/ESC/ACCP) guideline recommendations for the assessment of
 ==[Name of the Score] Calculator==
@@ Line 39: / Line 22: @@
 (insert widget here)
+<nowiki>{{#widget:Widget_Name}}</nowiki>
+==Interpretation==
+* Score ≤ 1: low-risk (&lt; 1% mortality); no treatment or hospital admission is required.
+* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
+* Score ≥ 4: high-risk (&gt; 5% mortality); treatment/hospitalization is warranted.
 ==See also==